// App-Quantinova.ai

e23100 : Exploring the utility of exosomal HER receptor dimerization as a resistance mechanism in NSCLC.

Researchers

Presenter

  • Myria Galazi

Principal Investigators

  • Gregory Weitsman

  • James Monypenny

  • Oana Coban

  • Jose Vicencio

  • Frank McCaughan

  • Martin David Forster

  • Tony Ng

Medical Centers

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Kings College London, London, United Kingdom

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved